GES: A validated simple score to predict the risk of HCC in patients with HCV-GT4-associated advanced liver fibrosis after oral antivirals.
Gamal ShihaImam WakedReham SolimanMohamed ElbasionyAsmaa I GomaaNabiel N H MikhailMohammed EslamPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
GES score is simple with validated good predictive ability for the development of HCC after eradication of HCV and may be useful for HCC risk stratification in those patients.